Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination.

Ther Adv Neurol Disord · 2022 · PMC9742512 · PMID 36518553

Europe PMC DOI

hedged sentence

0.0838

closest p · 1.7× alpha

0.0838

boldest claim

The sentences

showed a trendp = 0.0838so close (0.05 < p ≤ 0.1)

The CD8 + cytotoxic T cells showed a trend to be increased in aCD20 compared with HCs [HCs 17.3 ± 2.1; aCD20 21.6 ± 1.0; p = 0.0838; Figure 3(c) ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.